Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Dive into Digital Pathology Market

By Antti LuiroHead of Nordic ER Development, Analyst
Aiforia Technologies

Steven Lynum, CEO of Epredia, shares his perspective on digital pathology market and role of AI software like Aiforia in pathology operations. Epredia is a partner and investor to Aiforia. Equity Analyst Antti Luiro interviews.

Topics
00:35 Epredia and the CEO Steven Lynum
01:31 Epredia’s connection to Aiforia
02:07 Digital Pathology market
03:37 Market maturity and the key drivers
07:47 The current level of activity
08:39 The role of automated image analysis
13:15 Competitive approaches and major players in the market
14:37 Different clients
16:25 Partnership with Aiforia

Recent videos

Talenom - Planned demerger and strategies of Talenom and Easor
18.12.2025 klo 12.00 Talenom
Investing in the life science sector
18.12.2025 klo 08.47
Life Science Companies as Investments | Life Science Night Dec. 9, 2025
16.12.2025 klo 09.30 Aiforia Technologies
Truecaller, Webcast, Press Conference, 2025
15.12.2025 klo 14.00 Truecaller
Herantis Pharma as an Investment | Life Science Night Dec 9, 2025
15.12.2025 klo 14.00 Herantis Pharma
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.